Start | Grid View | Browse by Day OR Group/Topical | Author Index | Personal Scheduler

The Evolution of Quality by Design in Drug Substance Development

Monday, November 9, 2009: 9:07 AM
Hermitage D (Gaylord Opryland Hotel)

John Lepore, Chemical Process Development and Commercialization, Merck & Co., Inc., Rahway, NJ

tbd
Extended Abstract: File Not Uploaded
See more of this Session: QbD Topical Conference Plenary Session: Keynote Addresses
See more of this Group/Topical: Topical I: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture